Search results for "PLATINUM"

showing 10 items of 629 documents

Prognostic factors of overall survival for patients with FIGO stage IIIc or IVa ovarian cancer treated with neo-adjuvant chemotherapy followed by int…

2020

International audience; Introduction The aim of this study was to identify prognostic factors of overall survival in patients with FIGO stage IIIc or IVa ovarian cancer (OC) treated by neo-adjuvant chemotherapy (NAC) followed by interval debulking surgery.Materials and methods Data from 483 patients with ovarian cancer were retrospectively collected, from January 1, 2000 to December 31, 2016, from the FRANCOGYN database, regrouping data from 11 centers specialized in ovarian cancer treatment. Median overall survival was determined using the Kaplan-Meier method. Univariate and multivariate analysis were performed to define prognostic factors of overall survival.Results The median overall sur…

Neoplasm Residualmedicine.medical_treatmentGenes BRCA2FIGO Stage IIICGenes BRCA1Platinum CompoundsCarcinoma Ovarian EpithelialCohort Studies0302 clinical medicineAscitic FluidOverall survivalPeritoneal Lavage030212 general & internal medicineOvarian NeoplasmsUnivariate analysisCytoreduction Surgical ProceduresGeneral MedicineMiddle AgedPrognosisDebulkingNeoadjuvant Therapy3. Good healthSurvival RateOncology030220 oncology & carcinogenesisFemaleTaxoidsFranceOmentumCohort studymedicine.medical_specialty[SDV.CAN]Life Sciences [q-bio]/CancerAntineoplastic Agents[SDV.MHEP.GEO]Life Sciences [q-bio]/Human health and pathology/Gynecology and obstetricsInterval debulking surgeryNeoadjuvant chemotherapyPelvis03 medical and health sciences[SDV.CAN] Life Sciences [q-bio]/CancerOvarian cancerMedian follow-upmedicineHumansNeoplasm InvasivenessAgedNeoplasm StagingProportional Hazards Modelsbusiness.industryRetrospective cohort studymedicine.diseaseSurgery[SDV.MHEP.GEO] Life Sciences [q-bio]/Human health and pathology/Gynecology and obstetrics[SDV.SPEE] Life Sciences [q-bio]/Santé publique et épidémiologieMultivariate AnalysisLymph Node Excision[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologieSurgeryLymphadenectomyLymph NodesOvarian cancerbusinessEuropean Journal of Surgical Oncology
researchProduct

Voltammetric determination of platinum il leaves of Nerium oleander L. ; Preliminary data on assessment of air quality in the Palermo

2008

Nerium oleander Platinum voltammetric analysis
researchProduct

Highly siderophile elements (Re, Os, Ir, Ru, Rh, Pd, Au) in impact melts from three European impact craters (Sääksjärvi, Mien, and Dellen): Clues to …

1997

Twenty-two large (10 g) impact melt samples from three Scandinavian craters (i.e., Saaksjarvi, Finland; and Mien and Dellen, Sweden) were analyzed for highly siderophile elements (HSE: platinum group elements, Rh, and Au) by the nickel sulfide technique in combination with neutron activation. The ten impact melt samples from Saaksjarvi are enriched in Ir and other highly siderophile elements (Ir = 2.48 ± 0.73 ng/g) relative to average upper crust concentrations (0.03 ± 0.02 ng/g Ir). The twelve Dellen and Mien samples are marginally enriched in Ir (0.48 ± 0.23 ng/g for Dellen, and 0.37 ± 0.23 ng/g for Mien). The amount of meteoritic component corresponds to 0.5% of a nominal CI component fo…

Nickel sulfideAnalytical chemistryMineralogyPlatinum groupIron meteoritechemistry.chemical_compoundImpact craterMeteoritechemistryGeochemistry and PetrologyBaltic ShieldRefractory (planetary science)GeologyNeutron activationGeochimica et Cosmochimica Acta
researchProduct

Clues to the nature of the impacting bodies from platinum-group elements (rhenium and gold) in borehole samples from the Clearwater East crater (Cana…

1997

— Seven large (10 g) impact melt rock samples from boreholes from the Boltysh impact crater (Ukraine) and six samples from the East Clearwater crater (Canada) were analyzed for Os, Ir, Ru, Rh, Pd, Re and Au by the nickel sulfide technique in combination with neutron activation. Earlier analyses of Clearwater East impact melt rocks have shown that they are strongly enriched in Ir, Os, Pd and Re. In this work, I confirm earlier findings and demonstrate similarly high enrichments of Rh and Ru. The average Os/Ir, Ru/Ir, Pd/Ir, Rh/Ir and Ru/Rh ratios of the melt rock samples from Clearwater East are CI-chondritic and yield an average Ir content of 25.2 ± 6.5 ng/g relative to an average upper cru…

Nickel sulfideBoreholeMineralogychemistry.chemical_elementRheniumPlatinum groupchemistry.chemical_compoundGeophysicsImpact craterchemistrySpace and Planetary ScienceUpper crustRefractory (planetary science)GeologyNeutron activationMeteoritics & Planetary Science
researchProduct

Nucleophilic attack by 2-pyridylpalladium(II) and platinum(II) complexes on the organic chlorides ClCH2R (R  COMe, CN, Ph, Cl)

1992

Abstract The 2-pyridyl complexes trans-[MCl(C5H4NC2)(PPh3)2] (M = Pd, 1a; M = Pt, 1b), [MCl(C5H4NC2)(dppe)] (M = Pd, 2a; M = Pt, 2b) and [M(dmtc)(C5H4NC2) (PPh3)] (M = Pd, 3a; M = Pt,3b) react with the chlorides ClCH2R(R  COMe, CN, Ph) to give cationic products containing the 2-pyridylium ligands (1-CH2R)C5H4NC2. The rate of nucleophilic displacement of the chloride ion from ClCH2R depends on the central metal (Pt > Pd), on the coordination geometry (1 ~ 3) and on the substituent R (COMe > CN > Ph for the reactions with 3b). Like 1b and 2b, complex 3b also reacts with dichloromethane to give [Pt(dmtc){(1-CH2Cl)C5H4NC2}(PPh3)]+. The reaction of the binuclear compound [{PdCl(μ-C5H4NC2,…

NitrileStereochemistryOrganic ChemistryCationic polymerizationchemistry.chemical_elementBiochemistryMedicinal chemistryInorganic Chemistrychemistry.chemical_compoundPerchlorateChloroacetonechemistryNucleophileMaterials ChemistryNucleophilic substitutionPhysical and Theoretical ChemistryPlatinumCoordination geometryJournal of Organometallic Chemistry
researchProduct

Pt(II) nitrile complexes: New insights on old complexes from a combined experimental and theoretical study

2017

Abstract The spectroscopic characterization of cis - and trans -[PtCl 2 (NCR) 2 ] (R = CH 3 , Ph, CH 2 Ph) was reported in solid state and solution phase. Moreover, the X-ray structures of cis -[PtCl 2 (NCCH 3 ) 2 ], cis - and trans -[PtCl 2 (NCPh) 2 ] were redetermined at low temperature. FT-IR and NMR showed a blue-shift and a slight shielding of the νCN and δ ( 13 C CN ) values, respectively, in a counterintuitive way with respect to the well known improved reactivity towards nucleophiles of nitriles ligands coordinated to platinum(II), when compared to their free forms. These spectroscopic behaviors were also confirmed by theoretical experiments at DFT level. Moreover, DFT approach show…

NitrileStereochemistrySolid-statechemistry.chemical_elementTheoretical calculations010402 general chemistry01 natural sciencesMedicinal chemistryCP MAS NMR studyInorganic Chemistrychemistry.chemical_compoundNucleophilePlatinum nitrile complexesMaterials ChemistryOrbital controlReactivity (chemistry)Platinum nitrile complexePhysical and Theoretical Chemistry010405 organic chemistrySolution phase0104 chemical sciencesBenzonitrilechemistrySettore CHIM/03 - Chimica Generale E InorganicaCP MAS NMR study; Platinum nitrile complexes; Spectroscopic characterization; Theoretical calculationsSpectroscopic characterizationPlatinum
researchProduct

Quasiparticle alignments and α-decay fine structure of 175Pt

2014

Excited states and decay properties of 175Pt have been investigated using the 92Mo(86Sr,2pn) fusion-evaporation reaction. The JUROGAM I γ -ray spectrometer and the GREAT spectrometer were used in conjunction with the gas-filled recoil separator RITU for the measurement of the radiation at the target and focal plane positions, respectively. Two new band structures, assigned to be based on the I π = (7/2 −) ground state in 175Pt, have been established and the known yrast band has been extended up to I π = (49/2 +). Rotational properties of the excited states in 175Pt have been investigated within the cranked shell-model formalism. The low-frequency changes in the alignments of the positive- a…

Nuclear Experimentquasiparticle alignmentsdeficient platinum isotopesnuclear-data sheets
researchProduct

Minimally invasive secondary cytoreduction plus HIPEC for recurrent ovarian cancer: a case series.

2014

Objective To analyze the feasibility of laparoscopic/robotic secondary cytoreductive surgery and hyperthermic intraperitoneal intra-operative chemotherapy (SCS + HIPEC) in a retrospective series of isolated platinum sensitive recurrent ovarian cancer. Methods We retrospectively evaluated a consecutive series of ovarian cancer patients with isolated platinum sensitive relapse. Isolated relapse was defined as the presence of a single nodule, in a single anatomic site. In all cases the presence of isolated relapse was assessed at pre-operative FDG-PET/CT scan, and confirmed with staging laparoscopy performed immediately before SCS + HIPEC. Results 84 women with platinum sensitive relapse recei…

OVARIAN CANEROrganoplatinum Compoundsmedicine.medical_treatmentdrug therapy/pathology/surgery/therapyCarcinoma Ovarian EpithelialMultimodal ImagingCohort StudiesObstetrics and gynaecologyNeoplasmsAntineoplastic Combined Chemotherapy ProtocolsInfusions ParenteralNeoplasms Glandular and EpithelialLaparoscopyadministration /&/ dosageTomographyRandomized Controlled Trials as TopicOvarian Neoplasmsmedicine.diagnostic_testObstetrics and GynecologyGlandular and EpithelialMiddle AgedDebulkingCombined Modality TherapyIsolated platinum sensitive relapseX-Ray ComputedOxaliplatinPhase III as TopicOncologyFemalediagnostic usemedicine.drugmedicine.medical_specialtyInfusionsAged Antineoplastic Combined Chemotherapy Protocols; administration /&/ dosage Cisplatin; administration /&/ dosage Clinical Trials; Phase II as Topic Clinical Trials; Phase III as Topic Cohort Studies Combined Modality Therapy Female Fluorodeoxyglucose F18; diagnostic use Humans Hyperthermia; Induced; methods Infusions; Parenteral Middle Aged Minimally Invasive Surgical Procedures Multimodal Imaging Neoplasms; Glandular and Epithelial; drug therapy/pathology/surgery/therapy Organoplatinum Compounds; administration /&/ dosage Ovarian Neoplasms; drug therapy/pathology/surgery/therapy Positron-Emission Tomography Radiopharmaceuticals; diagnostic use Randomized Controlled Trials as Topic Retrospective Studies Tomography; X-Ray Computed ocal; pathologyocalmethodsClinical Trials Phase II as TopicMinimally invasive surgeryOvarian cancerFluorodeoxyglucose F18ParenteralmedicineHumansMinimally Invasive Surgical ProceduresClinical TrialsHyperthermiaAgedRetrospective StudiesCisplatinChemotherapySeries (stratigraphy)HIPECbusiness.industryPhase II as TopicInducedHyperthermia Inducedmedicine.diseaseOxaliplatinSurgeryRoboticSettore MED/40 - GINECOLOGIA E OSTETRICIAClinical Trials Phase III as TopicPositron-Emission TomographyLaparoscopypathologyNeoplasm Recurrence LocalCisplatinRadiopharmaceuticalsbusinessOvarian cancerTomography X-Ray Computed
researchProduct

TRIPLET SCHEDULE OF WEEKLY 5-FLUOROURACIL AND ALTERNATING IRINOTECAN OR OXALIPLATIN IN ADVANCED COLORECTAL CANCER: A DOSE-FINDING AND PHASE II STUDY.

2010

A weekly administration of alternating irinotecan or oxaliplatin associated to 5-Fluorouracil in advanced colorectal cancer was planned in order to evaluate a new schedule maintaining dose intensities of each drug as in double combinations and tolerability of the triplet association. The following weekly schedule was administered: irinotecan, days 1 and 15; oxaliplatin, days 8 and 22; 5-fluorouracil (5-FU) over 12-h (from 10:00 p.m. to 10:00 a.m.) timed flat infusion, days 1-2, 8-9, 15-16 and 22-23, every 4 weeks. Dose- finding and phase II study were planned. Thirteen patients were enrolled in the dose-finding study and 23 in the phase II study. The recommended doses of our study are: irin…

OncologyAdultMaleCancer Researchmedicine.medical_specialtyLung NeoplasmsMaximum Tolerated DoseOrganoplatinum CompoundsSettore MED/06 - Oncologia Medica5-FluorouracilPhases of clinical researchIrinotecanGastroenterologyInternal medicineCPT-11Antineoplastic Combined Chemotherapy ProtocolsmedicineHumansAdvanced colorectal cancerAgedDose-Response Relationship Drugbusiness.industryLiver NeoplasmsGeneral MedicineMiddle Agedmedicine.diseaseOxaliplatinIrinotecanOxaliplatinSurvival RateRegimenTreatment OutcomeOncologyTolerabilityFluorouracilLymphatic MetastasisToxicityl-OHPCamptothecinFemaleFluorouracilbusinessColorectal NeoplasmsFebrile neutropeniamedicine.drug
researchProduct

Biweekly oxaliplatin plus irinotecan and folinic acid-modulated 5-fluorouracil: a phase II study in pretreated patients with metastatic colorectal ca…

2006

Oxaliplatin (OXA) and irinotecan (IRI) are active drugs for metastatic colorectal cancer, their toxicity profiles are not overlapping, and both drugs have shown at least additivity with folinic acid-modulated 5-fluorouracil (5FU). We carried out this phase II study to assess the activity and toxicity of a biweekly regimen including OXA plus IRI on day 1, and levo-folinic acid (LFA) plus 5FU on day 2 (OXIRIFAFU) in pretreated patients with metastatic colorectal cancer. Forty-one patients, all previously treated with adjuvant and/or palliative 5FU-based chemotherapy (16 of them already exposed to IRI, OXA or both), were enrolled into this trial. On the basis of sensitivity to previous treatme…

OncologyAdultMaleCancer Researchmedicine.medical_specialtyOrganoplatinum CompoundsColorectal cancerLeucovorinPhases of clinical researchIrinotecanDrug Administration ScheduleFolinic acidInternal medicineAntineoplastic Combined Chemotherapy ProtocolsmedicineHumansPharmacology (medical)Neoplasm MetastasisAgedPharmacologybusiness.industryMiddle Agedmedicine.diseasedigestive system diseasesSurgeryOxaliplatinIrinotecanOxaliplatinOncologyFluorouracilToxicityInjections IntravenousDisease ProgressionCamptothecinFemaleFluorouracilbusinessColorectal Neoplasmsmedicine.drugAnti-cancer drugs
researchProduct